MedPath

Black seed effects on coronary heart disease

Phase 3
Completed
Conditions
Coronary Heart Disease.
Chronic ischemic heart disease, unspecified
I25.9
Registration Number
IRCT20170513033941N61
Lead Sponsor
Vice chancellor for research, Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
70
Inclusion Criteria

Patients aged 45-85 years
People diagnosed with type 2 diabetes and coronary heart disease

Exclusion Criteria

Patients with thyroid disorders.
Severe renal insufficiency
hepatic failure
Those experiencing an acute myocardial infarction within the past 3 months
Patients undergoing cardiac surgery within the past 3 months

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Insulin resistance. Timepoint: At the beginning of the study and after 24 weeks of intervention. Method of measurement: Calculation using homeostasis model of assessment insulin resistance formula.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath